KRAS, NRAS,BRAF mutation testing Doctors Abroad — Page 3

Dr. Sridhar P.S. is a radiation oncology expert at HCG Manavata Cancer Centre. He leads cases requiring precise KRAS, NRAS, and BRAF mutation testing.

• Holds a Doctor of Medicine in radiotherapy from Banaras Hindu University
• Certified by the National Board of Examinations in radiotherapy
• Member of the Association of Radiation Oncology of India
• Belongs to the Society for Neuro-Oncology for specialized brain tumor knowledge
• Member of the Indian Association of Hyperthermia Oncology

Dr. Lalit Banswal has performed 10,000 major surgeries. He uses KRAS, NRAS, and BRAF mutation testing to guide surgical treatment for gastrointestinal cancers.

• Fellowship-trained in surgical oncology at Tata Medical Centre in Kolkata
• Serves as Assistant Professor at the State Cancer Institute
• Specializes in robotic and laparoscopic surgery for colon and rectal cancers
• Experienced lead investigator for clinical research in gastrointestinal oncology
• Member of the surgical oncology team at HCG Manavata Cancer Centre

Dr. Shaunak Valame is a medical oncologist at HCG Manavata Cancer Centre. He specializes in molecular oncology to guide KRAS, NRAS, and BRAF mutation testing for targeted therapy.

• Earned a DNB in Medical Oncology from the prestigious Indraprastha Apollo Hospital
• Presented stomach cancer research at the ASCO Gastrointestinal Cancer Symposium in San Francisco
• Member of the American Society of Clinical Oncology (ASCO)
• Former lecturer for the International Winter School of Oncology at AIIMS Bhopal
• Provides precision treatment for lung, breast, and gastrointestinal cancers

Professor Kayihan Engin is the Director of Oncological Sciences at Medicana Bursa Hospital. He manages gastrointestinal tumor cases where KRAS, NRAS, and BRAF mutation testing is essential for treatment planning.

• Completed a post-doctoral fellowship at Thomas Jefferson University in the USA
• Former Coordinator of Oncological Sciences at the Anadolu Medical Center
• Expert in gastrointestinal tumors including colorectal, esophageal, and liver cancers
• Conducted advanced research at the National Cancer Institute in Bethesda
• Served as Chairman of Radiation Oncology at Uludağ University Medical College

Dr. Antonio Cubillo Gracián pioneered the first liquid biopsy program in Spain. He uses genetic data to guide KRAS, NRAS, and BRAF mutation testing for targeted therapy.

• Heads the Medical Oncology Service at Hospital Universitario HM Sanchinarro
• Directs postgraduate research at HM CIOCC, a leading Spanish cancer center
• Uses molecular markers like EGFR and ALK to design personalized cancer treatment plans
• Leads clinical trials for new cancer therapies through the Start Madrid program
• Member of the teacher faculty at USP CEU medical school

Dr. Raj Nagarkar has performed 50,000+ cancer surgeries. He leads HCG Manavata Cancer Centre, where KRAS, NRAS, and BRAF mutation testing guides surgical planning.

• Completed surgical oncology residency at Tata Memorial Hospital in Mumbai
• Member of the Royal College of Surgeons of Edinburgh
• Participated in over 200 Phase 1–3 clinical trials
• Professor for DNB Superspecialty Surgical Oncology – training future cancer surgeons
• Treats complex cases of liver, pancreatic, and colorectal cancers